186 related articles for article (PubMed ID: 23330005)
1. Expression of XPG protein in human normal and tumor tissues.
Aracil M; Dauffenbach LM; Diez MM; Richeh R; Moneo V; Leal JF; Fernández LF; Kerfoot CA; Galmarini CM
Int J Clin Exp Pathol; 2013; 6(2):199-211. PubMed ID: 23330005
[TBL] [Abstract][Full Text] [Related]
2. XPG stabilizes TFIIH, allowing transactivation of nuclear receptors: implications for Cockayne syndrome in XP-G/CS patients.
Ito S; Kuraoka I; Chymkowitch P; Compe E; Takedachi A; Ishigami C; Coin F; Egly JM; Tanaka K
Mol Cell; 2007 Apr; 26(2):231-43. PubMed ID: 17466625
[TBL] [Abstract][Full Text] [Related]
3. Human XPG nuclease structure, assembly, and activities with insights for neurodegeneration and cancer from pathogenic mutations.
Tsutakawa SE; Sarker AH; Ng C; Arvai AS; Shin DS; Shih B; Jiang S; Thwin AC; Tsai MS; Willcox A; Her MZ; Trego KS; Raetz AG; Rosenberg D; Bacolla A; Hammel M; Griffith JD; Cooper PK; Tainer JA
Proc Natl Acad Sci U S A; 2020 Jun; 117(25):14127-14138. PubMed ID: 32522879
[TBL] [Abstract][Full Text] [Related]
4. New insights into the combined Cockayne/xeroderma pigmentosum complex: human XPG protein can function in transcription factor stability.
Friedberg EC; Wood RD
Mol Cell; 2007 Apr; 26(2):162-4. PubMed ID: 17466619
[TBL] [Abstract][Full Text] [Related]
5. Characterization of three XPG-defective patients identifies three missense mutations that impair repair and transcription.
Schäfer A; Schubert S; Gratchev A; Seebode C; Apel A; Laspe P; Hofmann L; Ohlenbusch A; Mori T; Kobayashi N; Schürer A; Schön MP; Emmert S
J Invest Dermatol; 2013 Jul; 133(7):1841-9. PubMed ID: 23370536
[TBL] [Abstract][Full Text] [Related]
6. Regulation of Transcription Elongation by the XPG-TFIIH Complex Is Implicated in Cockayne Syndrome.
Narita T; Narita K; Takedachi A; Saijo M; Tanaka K
Mol Cell Biol; 2015 Sep; 35(18):3178-88. PubMed ID: 26149386
[TBL] [Abstract][Full Text] [Related]
7. A stable XPG protein is required for proper ribosome biogenesis: Insights on the phenotype of combinate Xeroderma Pigmentosum/Cockayne Syndrome patients.
Taupelet F; Donnio LM; Magnani C; Mari PO; Giglia-Mari G
PLoS One; 2022; 17(7):e0271246. PubMed ID: 35802638
[TBL] [Abstract][Full Text] [Related]
8. Hot topics in DNA repair: the molecular basis for different disease states caused by mutations in TFIIH and XPG.
Schärer OD
DNA Repair (Amst); 2008 Feb; 7(2):339-44. PubMed ID: 18077223
[TBL] [Abstract][Full Text] [Related]
9. The founding members of xeroderma pigmentosum group G produce XPG protein with severely impaired endonuclease activity.
Lalle P; Nouspikel T; Constantinou A; Thorel F; Clarkson SG
J Invest Dermatol; 2002 Feb; 118(2):344-51. PubMed ID: 11841555
[TBL] [Abstract][Full Text] [Related]
10. Novel XPG (ERCC5) mutations affect DNA repair and cell survival after ultraviolet but not oxidative stress.
Soltys DT; Rocha CR; Lerner LK; de Souza TA; Munford V; Cabral F; Nardo T; Stefanini M; Sarasin A; Cabral-Neto JB; Menck CF
Hum Mutat; 2013 Mar; 34(3):481-9. PubMed ID: 23255472
[TBL] [Abstract][Full Text] [Related]
11. A common mutational pattern in Cockayne syndrome patients from xeroderma pigmentosum group G: implications for a second XPG function.
Nouspikel T; Lalle P; Leadon SA; Cooper PK; Clarkson SG
Proc Natl Acad Sci U S A; 1997 Apr; 94(7):3116-21. PubMed ID: 9096355
[TBL] [Abstract][Full Text] [Related]
12. Non-catalytic Roles for XPG with BRCA1 and BRCA2 in Homologous Recombination and Genome Stability.
Trego KS; Groesser T; Davalos AR; Parplys AC; Zhao W; Nelson MR; Hlaing A; Shih B; Rydberg B; Pluth JM; Tsai MS; Hoeijmakers JHJ; Sung P; Wiese C; Campisi J; Cooper PK
Mol Cell; 2016 Feb; 61(4):535-546. PubMed ID: 26833090
[TBL] [Abstract][Full Text] [Related]
13. Cyclosporin A inhibits nucleotide excision repair via downregulation of the xeroderma pigmentosum group A and G proteins, which is mediated by calcineurin inhibition.
Kuschal C; Thoms KM; Boeckmann L; Laspe P; Apel A; Schön MP; Emmert S
Exp Dermatol; 2011 Oct; 20(10):795-9. PubMed ID: 21707758
[TBL] [Abstract][Full Text] [Related]
14. Defective transcription-coupled repair of oxidative base damage in Cockayne syndrome patients from XP group G.
Cooper PK; Nouspikel T; Clarkson SG; Leadon SA
Science; 1997 Feb; 275(5302):990-3. PubMed ID: 9020084
[TBL] [Abstract][Full Text] [Related]
15. Genetic polymorphisms of the XPG and XPD nucleotide excision repair genes in sarcoma patients.
Le Morvan V; Longy M; Bonaïti-Pellié C; Bui B; Houédé N; Coindre JM; Robert J; Pourquier P
Int J Cancer; 2006 Oct; 119(7):1732-5. PubMed ID: 16646069
[TBL] [Abstract][Full Text] [Related]
16. Polymorphisms of XPG/ERCC5 and risk of squamous cell carcinoma of the head and neck.
Ma H; Yu H; Liu Z; Wang LE; Sturgis EM; Wei Q
Pharmacogenet Genomics; 2012 Jan; 22(1):50-7. PubMed ID: 22108238
[TBL] [Abstract][Full Text] [Related]
17. XPG: a multitasking genome caretaker.
Muniesa-Vargas A; Theil AF; Ribeiro-Silva C; Vermeulen W; Lans H
Cell Mol Life Sci; 2022 Mar; 79(3):166. PubMed ID: 35230528
[TBL] [Abstract][Full Text] [Related]
18. Mutations that disable the DNA repair gene XPG in a xeroderma pigmentosum group G patient.
Nouspikel T; Clarkson SG
Hum Mol Genet; 1994 Jun; 3(6):963-7. PubMed ID: 7951246
[TBL] [Abstract][Full Text] [Related]
19. XPG mRNA expression levels modulate prognosis in resected non-small-cell lung cancer in conjunction with BRCA1 and ERCC1 expression.
Bartolucci R; Wei J; Sanchez JJ; Perez-Roca L; Chaib I; Puma F; Farabi R; Mendez P; Roila F; Okamoto T; Taron M; Rosell R
Clin Lung Cancer; 2009 Jan; 10(1):47-52. PubMed ID: 19289372
[TBL] [Abstract][Full Text] [Related]
20. Xeroderma pigmentosum and molecular cloning of DNA repair genes.
Boulikas T
Anticancer Res; 1996; 16(2):693-708. PubMed ID: 8687116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
